Kolexia
Feve Bruno
Endocrinologie
Hôpital Saint-Antoine
Paris, France
234 Activités
323 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Insulinorésistance Obésité Diabète Lipodystrophie Inflammation Syndrome métabolique X Maladies métaboliques Stéatose hépatique Prise de poids

Industries

Sanofi
25 collaboration(s)
Dernière en 2023
Lilly
15 collaboration(s)
Dernière en 2023
AstraZeneca
8 collaboration(s)
Dernière en 2023
Bayer
4 collaboration(s)
Dernière en 2023

Dernières activités

Adipocyte glucocorticoid receptor activation with high glucocorticoid doses impairs healthy adipose tissue expansion by repressing angiogenesis.
Diabetes   14 novembre 2023
Diagnostic et prise en charge spécialisée des patients atteints de syndromes rares d’insulinorésistance : une étude de cohorte
39e congrès de la Société Française d'Endocrinologie 2023   01 octobre 2023
Sex-dependent association of the MAOA rs979605 genetic polymorphism on clinical improvement following antidepressant treatment in depressed patients
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
CYP2C19 genotyping escitalopram and citalopram blood concentrations in a cohort of patients: First results from the METADAP study
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
Metabolomic profiles of 38 acylcarnitines in major depressive episodes before and after treatment: Results from the METADAP and VARIETE cohorts
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
Metabolomic profiles of 38 acylcarnitines in major depressive episodes before and after treatment.
Psychological medicine   25 mai 2023
Perinatal, metabolic, and reproductive features in PPARG-related lipodystrophy.
European journal of endocrinology   06 mars 2023
Non-overweight depressed patients who respond to antidepressant treatment have a higher risk of later metabolic syndrome: findings from the METADAP cohort.
Psychological medicine   11 janvier 2023
The rs979605 Genetic Polymorphism Is Differentially Associated with Clinical Improvement Following Antidepressant Treatment between Male and Female Depressed Patients.
International journal of molecular sciences   28 décembre 2022
Batokines : les hormones du tissu adipeux brun
Médecine des Maladies Métaboliques   01 décembre 2022